Defiance ETFs has expanded the U.S. single-country ETF market with the launch of the Defiance KSM Israel 120 ETF, a Nasdaq-listed fund designed to give American investors broad access to companies trading in Israel’s domestic equity market. The fund, which trades under the ticker ISRL, was announced on September 1 in partnership with KSM US LLC, part of the KSM Group within The Phoenix Investment House. Rather than targeting a specific Israeli industry or a narrow group of globally recognized technology companies, ISRL is structured as a broad-market portfolio centered on securities listed on the Tel Aviv Stock Exchange.

The ETF seeks to track, before fees and expenses, the Israeli 120 iNDEX. The benchmark is calculated and administered by Index Research and Development Ltd., a subsidiary of TMX VettaFi Group. Its investable universe is drawn entirely from equity securities traded on the Tel Aviv Stock Exchange, while constituent companies must be incorporated or domiciled in Israel. That construction gives ISRL a distinctly local-market orientation and makes the fund a new option for U.S. investors seeking exposure beyond the Israeli companies that are most visible through American exchanges or global technology benchmarks.

The index can include common stocks, preferred shares and real estate investment trusts denominated in Israeli shekels. Securities must pass several investability screens. The methodology requires a market capitalization of at least 75 million Israeli shekels, a minimum free-float-adjusted market capitalization at the same threshold, sufficient three-month average daily trading activity and public float of at least 20%. The screens are intended to broaden the opportunity set while excluding securities whose size, tradability or ownership structure could make them impractical for an ETF portfolio.

Constituents are principally weighted by market capitalization, but ISRL does not simply replicate an unconstrained ranking of the largest Tel Aviv-listed companies. The benchmark allows a maximum of 120 issuers, caps individual company weights at 4% during the weighting process and establishes a 0.1% minimum weight. Excess weight from companies reaching the cap is redistributed among other constituents. The index is reconstituted and rebalanced quarterly, allowing its membership and position sizes to adjust as market capitalizations, liquidity and other eligibility factors change.

A less conventional feature is the benchmark’s profitability adjustment. Companies reporting negative annual net income in at least two of the five years preceding a rebalance can have their weighting factors reduced. The reduction ranges from 20% to 50%, depending on how frequently losses were reported. That mechanism introduces a quality-oriented element into an otherwise market-cap-based strategy. It does not exclude every loss-making business, but it can reduce the influence of companies with recurring negative earnings, potentially altering the portfolio relative to a conventional broad Israeli equity benchmark.

The fund normally intends to invest at least 80% of net assets in securities belonging to the Israeli 120 iNDEX. Defiance said implementation will generally use a replication approach, with the ETF owning local shares or, when available and appropriate, depositary receipts. As with other international ETFs that hold securities trading outside U.S. market hours, the structure introduces considerations around currency movements, valuation timing, underlying-market liquidity and differences between the trading session for ISRL shares and the trading hours of the Tel Aviv Stock Exchange.

ISRL carries an expense ratio of 0.59%. Tidal Investments LLC is the fund’s investment adviser, while Defiance ETFs LLC serves as sponsor and KSM US LLC as sub-sponsor. Foreside Fund Services LLC is the distributor. The arrangement illustrates an increasingly common ETF-industry model in which product sponsors, local-market specialists, index providers and established ETF infrastructure firms combine their capabilities to bring specialized strategies to U.S. exchanges without requiring each participant to build a complete fund-management platform independently.

KSM’s role is particularly relevant to the product’s positioning. The firm is part of The Phoenix Investment House, providing the launch with a connection to an established participant in Israel’s asset-management market. KSM and Defiance have worked together previously, including through the Defiance KSM TipRanks Analyst ETF. For ISRL, the partnership pairs that local-market connection with Defiance’s U.S. ETF distribution presence and TMX VettaFi’s index-development infrastructure.

Initial ISRL holdings illustrate the difference between a broad domestic-market allocation and an Israel strategy built mainly around internationally prominent technology names. Defiance holdings data dated September 1 showed Bank Leumi, Bank Hapoalim and Mizrahi Tefahot Bank among the largest positions. Other major holdings included defense company Elbit Systems, chipmaker Tower Semiconductor, Azrieli Group, Phoenix Financial, Teva Pharmaceutical Industries, Israel Discount Bank and Harel Insurance Investments & Financial Services.

That portfolio composition makes financial-sector exposure an important feature rather than a secondary characteristic. The fund’s disclosures state that financial services represented a significant portion of the underlying index around the launch. Banks, insurers and financial holding companies occupy several of the larger positions, meaning ISRL may react not only to developments in Israel’s technology and defense sectors but also to domestic credit conditions, interest rates, banking profitability, capital markets and the health of the Israeli economy more broadly.

The holdings nevertheless extend well beyond financial institutions. Semiconductor equipment and manufacturing companies, renewable-energy businesses, telecommunications providers, commercial real-estate groups, pharmaceuticals, traditional energy firms, retailers and industrial companies all appear in the portfolio. That cross-sector composition is central to ISRL’s investment case. Investors accustomed to viewing Israel mainly through the lens of cybersecurity, software or other technology exports are instead being offered a portfolio intended to reflect a wider cross-section of the domestic listed economy.

ISRL is entering a market where U.S. investors already have access to Israel-focused funds, so the competition will center on methodology, portfolio exposure, liquidity and investor acceptance rather than novelty alone. The iShares MSCI Israel ETF, or EIS, is a longstanding example. EIS launched in 2008, tracks the MSCI Israel Capped Investable Market Index and had about $886 million in net assets as of September 1, according to iShares. It also listed 121 holdings around late August and carries the same 0.59% expense ratio as ISRL.

That fee comparison means ISRL is unlikely to compete primarily by undercutting one of the category’s most established products. Instead, its differentiating proposition is the Israeli 120 iNDEX methodology and the requirement that the investable universe be composed of Tel Aviv Stock Exchange securities associated with companies incorporated or domiciled in Israel. Portfolio differences created by the benchmark’s eligibility requirements, issuer caps and profitability adjustments could become more important to investors than the headline management fee.

For asset allocators, country ETFs such as ISRL can serve several roles. They can be used as strategic allocations to a national equity market, tactical positions tied to economic or valuation views, components in regionally diversified portfolios, or complements to global benchmarks in which a particular country has only a small weighting. A dedicated Israel ETF can also allow an investor to increase or reduce exposure without selecting individual Israeli companies, navigating local brokerage arrangements or constructing a portfolio of depositary receipts.

The broad-market structure does not eliminate concentration risk. A portfolio of as many as 120 companies can still be heavily influenced by a relatively small number of sectors when the underlying national market itself is concentrated. Financial companies occupy prominent positions, while defense, technology and real estate can also become substantial performance drivers. The fund therefore provides diversification across issuers without necessarily providing the same economic diversification investors would receive from a global equity ETF spread across many countries and industries.

Country-specific risk is also material. ISRL’s prospectus identifies risks associated with Israeli issuers, geopolitical conditions, foreign securities, currency fluctuations and market liquidity. Investors buying ISRL in dollars are ultimately gaining exposure to securities whose local-market values are generally expressed in Israeli shekels. Changes in the shekel-dollar exchange rate can therefore affect U.S.-dollar returns independently of movements in the underlying share prices. Regional security developments can also generate abrupt changes in risk premiums, trading conditions and capital flows.

The fund’s status as a new ETF adds another practical consideration. An index methodology can be evaluated before launch, but spreads, secondary-market liquidity, creation and redemption activity and the depth of the investor base become visible only as trading develops. Investors evaluating ISRL will likely watch average daily volume, bid-ask spreads, premiums or discounts to net asset value and growth in assets under management alongside the portfolio’s investment performance. Those measures will be particularly important for institutions or advisers considering larger allocations.

The launch also fits a broader evolution in the ETF industry toward increasingly precise geographic and thematic exposures. Issuers are no longer limited to duplicating major global benchmark families. Partnerships with local asset managers and specialist index designers can produce portfolios whose rules reflect individual markets more closely. In ISRL’s case, the combination of a Tel Aviv-only universe, a 120-company ceiling, position caps and earnings-related adjustments creates an index that is recognizably broad market but still carries several active-like decisions embedded in its rules.

Those rules can affect performance meaningfully over time. Capping the largest issuers can reduce dependence on a handful of dominant companies, while setting minimum positions gives the smallest qualifying members some representation. The profitability adjustment may systematically shift weight away from companies with repeated annual losses. Such design choices can improve diversification or produce a different risk profile, but they can also cause the ETF to lag a conventional capitalization-weighted index when companies that have been capped or penalized subsequently outperform.

Quarterly rebalancing introduces another consideration. Frequent index reviews can help a portfolio respond to changes in market capitalization, liquidity and corporate fundamentals, but rebalancing can also generate portfolio turnover and transaction costs. Those effects are especially relevant when an index reaches further down the capitalization spectrum into smaller securities whose trading liquidity can be more limited than that of the largest Israeli companies. The fund’s tracking efficiency will therefore be a useful measure of how successfully the portfolio translates the index methodology into realized investor returns.

For Defiance, ISRL also represents a departure from the issuer’s highly visible lineup of leveraged single-stock, thematic and income-oriented products. Although the firm continues to operate extensively in specialized and higher-octane ETF categories, the Israel 120 fund is a conventional unleveraged index-tracking equity product. That broadens the company’s product mix and places Defiance in direct competition with larger asset managers in a country-allocation segment where investors often value portfolio transparency, liquidity, benchmark credibility and long operating histories.

The launch comes with no meaningful performance record of its own. Defiance lists the fund’s inception date as August 31, 2026, leaving investors initially dependent on the benchmark methodology, portfolio disclosures and structural characteristics rather than live fund results. Early asset growth will indicate whether advisers and investors see enough differentiation in ISRL’s TASE-centered construction to shift capital from established Israel funds or to create new allocations that previously were not represented in portfolios.

The most important distinction is therefore not that ISRL opens Israel to U.S. ETF investors for the first time; it does not. Its significance is that it packages a specific definition of the Israeli domestic equity market into a U.S.-listed security. With exposure reaching from leading banks and insurers to defense, semiconductors, pharmaceuticals, property companies, energy producers and smaller listed businesses, the fund offers investors another way to decide what “Israel equity exposure” should mean inside a diversified portfolio.

Whether that proposition gains traction will depend on more than the performance of Israeli shares. ISRL must also develop reliable trading liquidity, maintain close index tracking and demonstrate that its broader Tel Aviv-focused methodology produces an exposure investors find sufficiently distinct from established alternatives. With its 0.59% expense ratio offering little price advantage against the largest incumbent Israel ETF, portfolio construction and access are likely to remain the principal competitive arguments. The September launch gives the U.S. ETF market a new benchmark for testing investor demand for a more explicitly domestic representation of Israel’s listed corporate sector.